GlassScriptPhysician profile
Adam Franklin
NPI 1942595871
$3,762.47
in general payments reported to CMS, 2019-2025
19 companies · $1,045 in 2025
The $1,045 reported for 2025 was more than what a typical Plastic and Reconstructive Surgery provider received nationally (typical 2025 total: $445).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $183 · 2020: $333 · 2021: $267 · 2022: $425 · 2023: $592 · 2024: $916 · 2025: $1,045.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,554.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,553.74 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $1,084.72 | 2023-2025 | |
| Allergan, INC. | $755.80 | 2019-2022 | |
| Revance Therapeutics, INC. | $482.46 | 2024-2025 | Daxxify |
| Motiva USA, LLC | $370.43 | 2024-2025 | |
| Galderma Laboratories, L.P. | $214.97 | 2021-2025 | Dysport |
| Sientra, INC. | $154.65 | 2020-2022 | |
| Integra Lifesciences Corporation | $117.61 | 2022-2025 | Integra, Integra Dermal Regeneration Template, Surgimend |
| Davol INC. | $109.83 | 2023 | Phasix Mesh |
| Depuy Synthes Sales INC. | $101.95 | 2020 | |
| Kerecis Limited | $63.65 | 2024-2025 | Kerecis Omega3 Marigen, Kerecis Surgiclose, Kerecis Omega3 Surgiclose |
| Pacira Pharmaceuticals Incorporated | $43.89 | 2019-2020 | |
| Alon Medical Technology | $43.70 | 2025 | |
| Stryker Corporation | $43.56 | 2021-2022 | |
| Mentor Worldwide LLC | $42.42 | 2025 | Mentor Memorygel Resterilizable Gel Sizer, Artoura Breast Tissue Expander |
| Ethicon US, LLC | $40.00 | 2024 | Stratafix, Dermabond Prineo |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Merz North America, INC. | $33.33 | 2025 | |
| Lifenet Health | $24.48 | 2024 | Theragenesis Wound Matrix |
| Smith+Nephew, INC. | $20.97 | 2019 | |
| Vertex Pharmaceuticals Incorporated | $14.05 | 2024 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Adam Franklin listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.